BioCentury | Oct 12, 2019
Financial News
As newly public biotechs stumble out of gate, 89bio, Centogene join IPO queue
...SVB Leerink, Evercore ISI, Baird and BTIG. Shareholders with more than a 10% stake are DPE Deutsche Private Equity...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
